176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.50%
Revenue growth below 50% of MRVL's 9.11%. Michael Burry would check for competitive disadvantage risks.
-0.57%
Cost reduction while MRVL shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
4.89%
Gross profit growth below 50% of MRVL's 10.71%. Michael Burry would check for structural issues.
3.34%
Margin expansion exceeding 1.5x MRVL's 1.46%. David Dodd would verify competitive advantages.
2.47%
R&D growth less than half of MRVL's 6.18%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.92%
Operating expenses growth above 1.5x MRVL's 4.48%. Michael Burry would check for inefficiency.
3.46%
Total costs growth 50-75% of MRVL's 6.18%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
-1.02%
D&A reduction while MRVL shows 0.10% growth. Joel Greenblatt would examine efficiency.
-8.08%
EBITDA decline while MRVL shows 14.10% growth. Joel Greenblatt would examine position.
3.23%
EBITDA margin growth 50-75% of MRVL's 4.57%. Martin Whitman would scrutinize operations.
-10.62%
Operating income decline while MRVL shows 19.85% growth. Joel Greenblatt would examine position.
-11.94%
Operating margin decline while MRVL shows 9.84% growth. Joel Greenblatt would examine position.
17.76%
Similar other expenses growth to MRVL's 19.62%. Walter Schloss would investigate industry patterns.
-8.88%
Pre-tax income decline while MRVL shows 19.84% growth. Joel Greenblatt would examine position.
-10.23%
Pre-tax margin decline while MRVL shows 9.83% growth. Joel Greenblatt would examine position.
19.29%
Tax expense growth 1.1-1.25x MRVL's 16.08%. Bill Ackman would demand explanation.
-12.81%
Net income decline while MRVL shows 20.37% growth. Joel Greenblatt would examine position.
-14.09%
Net margin decline while MRVL shows 10.32% growth. Joel Greenblatt would examine position.
-13.51%
EPS decline while MRVL shows 21.43% growth. Joel Greenblatt would examine position.
-9.09%
Diluted EPS decline while MRVL shows 7.69% growth. Joel Greenblatt would examine position.
0.65%
Share count reduction below 50% of MRVL's 0.98%. Michael Burry would check for concerns.
1.38%
Diluted share reduction below 50% of MRVL's 0.99%. Michael Burry would check for concerns.